HOME >> BIOLOGY >> NEWS
Vaccine hope for sufferers of potentially fatal stomach bug

Scientists at The University of Nottingham have been awarded over 366,000 to help unravel the mystery of a stomach bug which causes gastric ulcers and cancer. Their research could lead to the development of a vaccine for those most at risk.

The bacterium, Helicobacter pylori (Hp), lives in the stomachs of approximately half the worlds population. Dr Karen Robinson, a lecturer at the Centre of Biomolecular Sciences and co-researcher John Atherton, Professor of Gastroenterology and Head of the Wolfson Digestive Diseases Centre, lead a team of scientists that have spent the last three years trying to discover why most people are immune to the bug while it can cause potentially fatal disease in some people.

Dr Robinson says this new funding, from the Medical Research Council, will allow them to address one of the most important questions in Helicobacter research why some infected individuals develop ulcers or gastric cancer whilst others remain asymptomatic. My interest is in the immune response and how this dictates whether or not an infected person goes on to develop disease.

In recent studies the team has shown that the bacteria induce changes to the immune system which calm the inflammation down. However, sometimes this relationship goes wrong. Their experiments showed that people with ulcers often have a suppressed protective response, leading to the development of severe inflammation and ulceration of the stomach lining.

If we become infected with Hp it generally happens in childhood. The bacteria can remain undetected in the stomach for life. However, in some people it causes inflammation which leads to gastric ulcers or cancer in later years. Scientists at The University of Nottingham believe the Hp manipulates the immune system and patients arent aware of a problem until the disease has become so advanced they need surgery or chemotherapy.

The occurrence of the disease is currently thought to be due to
'"/>

Contact: Karen Robinson
44-011-582-31094
University of Nottingham
26-Apr-2007


Page: 1 2

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine prevents prion disease in mice
4. Vaccine to cope with viral diversity in HIV
5. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
6. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
7. Vaccine-producing plant-factories
8. HPV Vaccine: Whats next
9. Vaccine shown effective against chancroid
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... , ... May 20, 2020 , ... Law Enforcement has ... danger for all of us. The positions of these men and women put them ... defense for not following rules precisely. Officers have always had to face very high ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... helps Life Science Manufacturers accurately and easily project contracted liabilities with payers, ... Gross-to-Net models by projecting discounts/rebates to Commercial and Government entities, Copay and ...
(Date:5/11/2020)... ... May 11, 2020 , ... Octagos Health, a Houston-based ... implanted cardiac devices. The Octagos software allows healthcare professionals access to cardiac patients’ ... the management of remote transmissions and at the same time provides real-time patient ...
Breaking Biology News(10 mins):
(Date:4/7/2020)... Pa. (PRWEB) , ... April 06, 2020 , ... ... and process solutions for the life sciences industry, has announced the release of ... developing quickly, our top priority is the health and safety of our employees ...
(Date:4/1/2020)... ... March 30, 2020 , ... A joint venture ... (RID), formed earlier this year to bring telehealth to various government agencies, has ... COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from the ...
(Date:4/1/2020)... (PRWEB) , ... March 31, 2020 , ... Carterra® Inc., ... for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA™ platform to ... candidates to the clinic as early as this summer. , La Jolla Institute ...
(Date:3/27/2020)... MANHATTAN, Kansas (PRWEB) , ... ... ... LLC proudly announces the opening of its veterinary histopathology laboratory located centrally ... offer partnering clients the ability to work with a highly motivated, independent, ...
Breaking Biology Technology:
Cached News: